Wellfully Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Wellfully han disminuido a una tasa media anual de -37.1%, mientras que en la industria Pharmaceuticals los beneficios crecieron en un 35.1% anualmente. Los ingresos han ido disminuyendo a una tasa media de 4.5% al año.

Información clave

-37.1%

Tasa de crecimiento de los beneficios

-15.0%

Tasa de crecimiento del BPA

Crecimiento de la industria Pharmaceuticals	31.2%
Tasa de crecimiento de los ingresos	-4.5%
Rentabilidad financiera	n/a
Margen neto	-469.0%
Última actualización de beneficios	31 Dec 2022

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero Wellfully. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

CHIA:WFL Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 22	2	-8	7
30 Sep 22	2	-8	7
30 Jun 22	3	-7	7
31 Mar 22	2	-7	7
31 Dec 21	1	-7	7
30 Sep 21	1	-7	6
30 Jun 21	1	-6	6
31 Mar 21	1	-6	5
31 Dec 20	1	-6	5
30 Sep 20	1	-5	5
30 Jun 20	1	-4	4
31 Mar 20	2	-3	4
31 Dec 19	3	-2	4
30 Sep 19	3	-2	4
30 Jun 19	3	-2	4
31 Mar 19	2	-2	3
31 Dec 18	2	-2	3
30 Sep 18	2	-2	3
30 Jun 18	2	-2	3
31 Mar 18	2	-1	3
31 Dec 17	2	-1	2
30 Sep 17	2	-2	3
30 Jun 17	2	-3	4
31 Mar 17	2	-4	5
31 Dec 16	2	-5	5
30 Sep 16	2	-4	5
30 Jun 16	2	-4	4
31 Mar 16	2	-3	4
31 Dec 15	2	-3	3
30 Sep 15	2	-3	3
30 Jun 15	2	-2	3
31 Mar 15	1	-2	3
31 Dec 14	1	-2	3
30 Sep 14	1	-2	3
30 Jun 14	1	-2	3
31 Mar 14	1	-2	2
31 Dec 13	1	-1	2
30 Sep 13	1	-1	2
30 Jun 13	1	-1	2
31 Mar 13	1	-2	2
31 Dec 12	0	-2	2

Ingresos de calidad: WFL actualmente no es rentable.

Margen de beneficios creciente: WFL actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: WFL no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 37.1% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de WFL en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: WFL no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Pharmaceuticals (26.6%).

Rentabilidad financiera

Alta ROE: El pasivo de WFL supera su activo, por lo que es difícil calcular su rentabilidad financiera.

Wellfully Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2022 earnings released: AU$0.031 loss per share (vs AU$0.041 loss in FY 2021)

Full year 2022 earnings released: AU$0.034 loss per share (vs AU$0.041 loss in FY 2021)

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Full year earnings released - AU$0.041 loss per share

Recent updates

Wellfully Limited, Annual General Meeting, Apr 26, 2024

Wellfully Limited Announces Board Changes

Wellfully Limited Appoints John Forrester as Director

No independent directors

Wellfully Limited Appoints David Wheeler as Non-Executive Director, Effective from 1 February 2023

Wellfully Limited Announces Step Down of Steven Schapera as Non-Executive Director, Effective 31 December 2022

Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.

Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.

Less than half of directors are independent

Wellfully Limited Appoints Andy Wortlock as Non-Executive Director

Wellfully Limited, Annual General Meeting, Nov 25, 2022

Full year 2022 earnings released: AU$0.031 loss per share (vs AU$0.041 loss in FY 2021)

Full year 2022 earnings released: AU$0.034 loss per share (vs AU$0.041 loss in FY 2021)

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.136528 million.

Wellfully Limited Announces Knee Patch Registered as A Medical Device

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.1 million.

Wellfully Limited announced that it expects to receive AUD 0.1 million in funding

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.13 million.

Wellfully Limited Announces Board Changes

Less than half of directors are independent

Wellfully Limited Announces Swisswell Knee Patch Successfully Registered as Medical Device in the USA

Wellfully Limited Announces Board Changes

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Independent Non-Executive Director Cameron Reynolds has left the company

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Wellfully Limited announced that it expects to receive AUD 4.75 million in funding

Wellfully Limited has announced a Derivatives Offering in the amount of AUD 0.112307 million.

Wellfully Limited Announces Business & Operational Update

Wellfully Limited Completes Its Scheduled Release of 20 Launches in 20 Weeks for Its RÉDUIT Brand

Full year earnings released - AU$0.041 loss per share

Wellfully Limited Signs A Content Partnership for Its RÉDUIT Brand with Victoria Beckham

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado